Elizabeth Yeu Lin Tarsus Pharmaceuticals, Inc. (TARS) insider trading activity

TARS Quotes by TradingView

Elizabeth Yeu Lin is Chief Medical Officer of Tarsus Pharmaceuticals, Inc.. Currently has a direct ownership of 5,350 shares of TARS, which is worth approximately $258,084. The most recent transaction as insider was on Jun 24, 2024, when has been sold 3,350 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.35K
0% 3M change
167.5% 12M change
Total Value Held $258,084

Elizabeth Yeu Lin Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 24 2024
BUY
Exercise of conversion of derivative security
-
3,350 Added 38.51%
5,350 Common Stock
Jun 16 2023
BUY
Exercise of conversion of derivative security
-
2,000 Added 50.0%
2,000 Common Stock

Also insider at

STAA
STAAR SURGICAL CO Healthcare
EYL

Elizabeth Yeu Lin

Chief Medical Officer
Irvine, CA

Track Institutional and Insider Activities on TARS

Follow Tarsus Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TARS shares.

Notify only if

Insider Trading

Get notified when an Tarsus Pharmaceuticals, Inc. insider buys or sells TARS shares.

Notify only if

News

Receive news related to Tarsus Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TARS